Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays (AI-COVID-Xr)
The Benefits of Artificial Intelligence Algorithms (CNNs) for Discriminating Between COVID-19 and Influenza Pneumonitis in an Emergency Department Using Chest X-Ray Examinations
Sponsor: Falcon Trading Iasi
This observational or N/A phase trial investigates COVID-19 and Flu Like Illness and is currently ongoing. Falcon Trading Iasi leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
May 2022 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — May 2022 [monthly]
Recruiting
▶ Show 2 earlier versions
-
May 2020 — Jan 2021 [monthly]
Recruiting
-
Apr 2020 — May 2020 [monthly]
Recruiting
First recorded
Mar 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Falcon Trading Iasi
- Professor Adrian Covic
- Romanian Academy of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .